We have compared the behavior of 1251-labeled asialoorosomucoid (ASOR) and '25I-labeled asialotriantennary glycopeptide (TRI) from a-l-protease inhibitor in the perfused rat liver. These two ligands are recognized and internalized by the Gal/GalNAc receptor system of hepatocytes.
nalized by the Gal/GalNAc receptor system of hepatocytes.
We found that both ligands could be efficiently degraded when continuously perfused through a liver at 37TC. However, as much as 51% of the internalized 1251-labeled TRI was rapidly (t½ = 3 min) released intact into the perfusion medium under conditions that permitted ligand-receptor association. In contrast, ASOR was totally degraded under these conditions. When dissociation was promoted (i.e., in the presence of GalNAc or EGTA), as much as 57% of the internalized ASOR was rapidly released (also intact). In each case, the shorter the initial internalization phase, the greater the proportion of ligand that was subsequently released. Neither the degree of receptor occupancy nor the temperature (16-370C) during the initial internalization phase influenced the rate or extent of the release process. Electron microscopic localization of internal ASOR-horseradish peroxidase conjugate demonstrated that peripheral endosomes were the major compartment labeled during exocytosis. We conclude that substantial fractions of both ligands rapidly return to the cell surface after internalization, ASOR bound to receptor and most of TRI free from receptor. The remaining ligand molecules enter the lysosomal pathway.
Eukaryotic cells have evolved the process of receptor-mediated endocytosis to efficiently internalize a wide variety of molecules (for review, see ref. 1) . The intracellular pathway taken by those ligands destined for degradation appears to be similar and involves rapid sequestration within coated vesicles, followed by transport to lysosomes via a system of smooth membrane vesicles, termed endosomes (2) . Until recently this pathway was considered unidirectional. However, several reports (3) (4) (5) (6) (7) indicate that a number of ligands eventually degraded in lysosomes can be released (exocytosed) in total or in part after their endocytosis by cells. The most dramatic examples of this phenomenon involve two ligands that are recognized by the Gal/GalNAc receptor of mammalian hepatocytes. Both (tris)galactoside (3) and asialotransferrin type 3 (4) appear not to be delivered to lysosomes at all after their internalization but are released intact into the circulation or medium. These two ligands differ in their carbohydrate structure, in that the (tris)galactoside possesses three terminal Gal residues (3), whereas asialotransferrin type 3 contains one biantennary-type and one triantennary-type oligosaccharide chain (8) . However, both ligands exhibit less complexity of carbohydrate structure than, for example, asialoorosomucoid (ASOR) (9), a ligand which is. totally degraded upon endocytosis (2) .
The Gal/GalNAc receptor on the surface of hepatocytes can discriminate among a wide variety of carbohydrate structures, as evidenced by markedly different affinities (Kd ranging from millimolar to nanomolar) for closely related oligosaccharide structures (10) . Recently, it has been shown that a "simple" asialotriantennary glycopeptide (TRI) derived from a-1-protease inhibitor can bind to this receptor with approximately the same affinity as that of ASOR (10), which possesses five N-acetyllactosamine-type chains (11) . Therefore, we compared the behavior of ASOR and TRI after their internalization to determine if exocytosis was related to the capacity of a ligand to bind receptor by one (TRI) or multiple (ASOR) oligosaccharide chains. We have found that both ligands are released but under different conditions. Up to 56% of the internalized ASOR is rapidly released (t,½ = 3-5 min) from the isolated perfused rat liver only under conditions that promote receptor-ligand dissociation. However, up to 52% of the internalized TRI can be released even under nondissociating conditions. We conclude that internalized TRI returns to the cell surface free from receptor, whereas ASOR remains associated with receptor during exocytosis. for undegraded ligand and 125I-as described below. The warming phase was terminated after 90-120 min, when there was no further release of both degraded and undegraded ligand and >90% of the cpm that had been taken up in the loading phase were in the perfusate. Internalized ligand was defined as that resistant to release from the liver in the presence of either 10 mM GalNAc or 4 mM EGTA. We have previously shown that >90% of surface-bound 125I-ASOR or ASOR-horseradish peroxidase (HRP) is released by the latter displacing agent (13) .
MATERIALS AND METHODS
Determination of Degraded and Intact Ligand. In the case of 125I-TRI, intact and degraded ligands were assayed by chromatography on G-10 columns (1 x 20 cm) equilibrated in 1 M acetic acid, which had been calibrated with intact ligand, iodide, monoiodotyrosine, and diiodotyrosine. The samples (50-200 1.d) were loaded onto the columns with 1 mg of KI and 100 jig of bovine serum albumin in 100 ,ul of 0.05 M Hepes buffer (pH 7.5). The radioactivity in the void volume was defined as undegraded ligand. By Bio-Gel P-4 chromatography (14) , it was determined that the intact glycopeptide in the perfusate had a relative molecular mass of =2,000. The amounts of intact and degraded 125I-ASOR were determined by either column chromatography using G-25 (1 x 20 cm) as described above or precipitation with 10% trichloroacetic acid. The amount of radioactivity in the acid pellets was found to be 12.5% more than that in the void column volumes of replicate samples. Therefore, when acid precipitation was the only method used to determine the amount of undegraded 125I-ASOR, the quantity was reduced by 12.5%. Recovery of the cpm from the columns was 94-96%, with 98% of the included volume cpm coincident with KI.
Kinetic data were analyzed by a nonlinear regression program (15) on a Heath H-89 microcomputer.
Electron Microscopy of Internalized ASOR-HRP Conjugate. Preparation of the ASOR-HRP conjugate was as described (2). Biopsies of liver (0.1-0.2 g) were taken at various intervals before and after the warming phase of the experiment. The tissue was cut into 2-3 mm2 pieces while immersed in cold fixative (16) . After 2 hr, the tissue was rinsed twice with 0.1 M sodium cacodylate buffer (pH 7.4) and further processed for HRP cytochemistry as described (2) . RESULTS 
AND DISCUSSION
A comparison of the uptake and degradation of 10 nM 1251 ASOR and 125I-TRI at a dose of 10 nM by the isolated, perfused rat liver at 37°C is shown in Fig. 1 . Both ligands were efficiently removed from the perfusate, with 50% cleared after 5-7 min. In the case of 125I-ASOR, all of the added ligand was metabolized to 1251-, whereas 17% of 125I-TRI remained intact. § Radioactivity in the form of 1251 appeared after a lag of -18 min for 125I-ASOR and -8 min for 125I-TRI. Presumably this difference was due to more rapid lysosomal degradation of the glycopeptide relative to the glycoprotein. However, despite the longer initial lag, the rate of appearance of 1251 was faster for 125I-ASOR (t½ = 42 min) than for 125I-TRI (t½ = 69 min). The apparent paradox of an earlier onset of release of 125I for 125I-TRI versus 125I-ASOR, yet a slower ongoing degradation rate for 125I-TRI, suggested that §The nature of the intact TRI that remained in the perfusate for up to 3 hr of perfusion time is unknown. However, this material was not cleared when added to the perfusate of a freshly isolated perfused liver. Therefore, it may represent the recently described biantennary glycan with an intercalating GlcNAc that is present in some glycopeptide preparations derived from a-1-protease inhibitor (17) . Alternatively, this fraction may have been modified by the liver during perfusion. a fraction of the glycopeptide might be undergoing several cycles of endo-and exocytosis before entering the degradation pathway.
To test this hypothesis, we examined the face of previously internalized ligands under conditions that promoted dissociation of any receptor-ligand complexes reappearing at the cell surface (Fig. 2) . We found that 65% of the 125I-TRI internalized after 5 min at 37°C (loading phase) was subsequently released undegraded when 10 mM GalNAc was present in the perfusate. The process could be described by first-order kinetics, with a t -3 min and a k = 0.18 min-l. The degraded material (12 I-) was released at a slower rate, with 50% of the radioactivity appearing by 40 min. Unexpectedly, 17% of the ASOR internalized under similar loading conditions was also released undegraded when 10 mM GalNAc was present in the perfusion medium. In addition, the firstorder kinetic constant of release was similar to that of TRI (k = 0.15 min-'). These results suggested that both ligands were undergoing several cycles of endo-and exocytosis.
We then examined the fate of previously internalized ligands under conditions that (i) promoted dissociation of receptor-ligand complexes (EGTA or GalNAc), (ii) prevented rebinding of endogenously dissociated ligand (excess ligand), or (iii) allowed both continued association of ligand and receptor and rebinding (no additions Either '25I-ASOR or 125I-TRI was added to isolated rat liver perfusates under the conditions indicated. The temperature-shift protocol was followed and undegraded ligand was determined.
graded with a loading time of 2 min (Table 1) . We do not currently understand why all internalized ligand is not released. Varying the temperature of loading (16-310C) or the loading dose of both ligands (0.1-10 nM) had no effect on the proportion of ligand released undegraded. We next examined the intracellular location of 1251 ASOR-HRP, a specific electron microscopic tracer for the asialoglycoprotein system, at various times during the warming phase (0.5-25 min). Under equivalent loading conditions, I-ASOR-HRP behaved identically to 125I-ASOR. In two experiments, livers exposed to this electron microscopic tracer for 2.5 min at 31-32TC subsequently exocytosed 64% and 54% of the internalized ligand in undegraded form with 4 mM EGTA as the displacing agent (see Table 1 , where ASOR gave 50-62%). Examination of the ASOR-HRP distribution in these livers at 0.5 min after the warming phase was begun revealed that 83-97% of the ligand was in the peripheral cytoplasm, in small vesicles and peripheral (type I) endosomes ( Fig. 3 and Table 2 ). Thus, at a time when rapid release of undegraded ligand was occurring, the predominant labeled structures were peripheral endosomes, suggesting that these structures are a major subcellular compartment involved in the exocytosis pathway. The fraction of type I endosomes and peripheral vesicles containing ASOR-HRP at 5 min (56-67%) was more than the amount of total cellular ligand that was committed to release (25-30% of the total ligand remaining within the cell at this time). However, when the ASOR-HRP distribution is expressed on a volume basis, the peripheral endosomes accounted for only 22% of the total volume of ASOR-HRP-positive structures at 5 min and 6% at 10 min. Because the actual concentration (number of molecules per unit volume) of ligand within the different endosome categories cannot be quantitated with ASOR-HRP, the exact number of ligand molecules in each compartment cannot be determined by this method.
Our results indicate that two Gal/GalNAc-terminating ligands of quite different carbohydrate complexity, both of which are ultimately degraded by hepatocytes, do not irreversibly enter the degradative pathway as a consequence of internalization, but cycle back out to the cell surface either bound to (ASOR) or free of (TRI) receptor. Further studies under more physiological conditions are needed to deterProc. Natl. Acad Sci. USA 81 (1984) Proc. Natl. Acad. Table  2 ) after the start of the warming phase. Sixty Data from two separate experiments are given for each time point and structure category.
*Quantitation was performed in two ways: (i) by determining the numbers of structures containing ASOR-HRP in different regions of hepatocytes, regardless of the size of each structure or (ii) by determining the relative volume contributed by each structure category, using a test lattice as described (18) . tLivers were loaded with ASOR-HRP for 2.5 min at 31-320C and cooled to 40C; surface ligand was removed with 4 mM EGTA before the warming phase was begun.
tCategories were defined as follows: small vesicles were round in profile and =100 nm in diameter; type I endosomes were peripheral vesicles and tubules >200 nm in at least one dimension; type II endosomes were small vesicles and tubules in the Golgi-lysosomal region; type III endosomes were large (>200 nm in diameter) vesicles in the Golgi-lysosome region, containing smaller vesicles or other inclusions. multiple cycles of endo-and exocytosis. In contrast, if a ligand contains multiple clusters of galactose residues, as does ASOR, it is not released during exocytosis and thus may have a greater probability for more direct lysosomal delivery.'
The function of exocytosis after receptor-mediated endocytosis in most cases is unknown but has been reported for low density lipoprotein in cultured aortic smooth cells (5), mannosylated bovine serum albumin and the mannose receptor in rat pulmonary macrophages (6) , insulin in fat cells (7) , and apotransferrin and its receptor in K562 cells (20) . In the transferrin system, reutilization of this iron-transport protein can occur after endocytosis, intracellular release of ferric iron by acidification within a prelysosomal vesicle, and return of the apotransferrin-receptor complex to the surface (20) . A similar acidification mechanism has also been suggested for the dissociation of asialoglycoproteins by the Gal/GalNAc receptor (21) . Although not inconsistent with such a mechanism, our results with TRI suggest that dissociation of ligand from receptor, by whatever mechanism, appears not to be the signal for routing of free ligand to lysosomes, because TRI can escape the cell in an unbound state. Furthermore, our results with ASOR support the notion that ligand-receptor dissociation is not the signal for (unoccupied) receptor recycling, because ASOR can reappear at the surface presumably still bound to the receptor with which it entered. Thus, we must conclude that the cellular mechanisms involved in the sorting of membranes and molecules in receptor-mediated endocytosis, at least of Gal/GalNAc-terminated ligands, are more complex and subtle than heretofore appreciated.
1We have observed this same phenomenon in isolated hepatocytes; however, the kinetics are slower than those reported here (unpublished data).
